High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Uncover creative ways to make money while consolidating debts, allowing you to pay off obligations faster and improve your financial situation.
27,644 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Retail investors on social forums are weighing the impact of a $1.2 billion withdrawal surge from BlackRock's private...
Friday's session put cybersecurity stocks in retreat as investors priced in AI-driven commoditization risks. Palo Alt...
Ford is retreating from broad EV production while Toyota accelerates its electrification push, setting up a decisive ...
As HubSpot prepares to report its 2026 earnings, investors want clarity on growth drivers, profitability, and strateg...
Jamie Dimon’s long tenure has anchored JPMORGAN CHASE through crises and growth. If he leaves, the bank faces a stage...
Chevron reports stronger-than-expected Q1 2026 results and advancing Hess synergy-driven production, but investors de...
Upstart has been navigating a challenging stretch as the stock declines. This article breaks down whether the drop cr...
This in-depth look at Repositrak (TRAK) 2026 earnings breaks down the drivers behind revenue growth, margin trends, a...
As traditional bonds yield less in a volatile rate environment, retirees are turning to covered-call ETFs such as JEP...
A major institutional move grabs attention as landmark investment partners cuts its stake in Howard Hughes Holdings. ...
A clear look at Copart's 2026 earnings outlook, the drivers behind revenue, and what this could mean for investors. R...